← Signals

Signal · Regulation & Trade

Recommendations for the Development of Blood Collection, Processing, and Storage Systems for the Manufacture of Blood Components Using the Buffy Coat Method; Guidance for Industry; Availability

US Federal Register - FDA (food, drug, device rules) Authoritative source Published 17th September 2026 United States

Open original report federalregister.gov

What the source reported

Source-reported

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance titled "Recommendations for the Development of Blood Collection, Processing, and Storage Systems for the Manufacture of Blood Components Using the Buffy Coat Method." The guidance document provides recommendations on the development of blood collection, processing, and storage systems (e.g., blood bags with anticoagulant and additive solutions, empty bags for platelet pooling) intended for the manufacture of blood and blood components for transfusion using the buffy coat (BC) method and on regulatory submissions to FDA for such products. This guidance is intended for manufacturers of blood collection, processing, and storage systems. The guidance announced in this notice finalizes the draft guidance of the same title dated October 18, 2024.

Publication
US Federal Register - FDA (food, drug, device rules) · Government/Regulator
Published
17th September 2026
Original report
federalregister.gov

ProcIntel stores what the source published in its feed — a headline, a summary and a link. It does not store or reproduce the full article.

What ProcIntel recorded

ProcIntel-derived
Category
Regulation & Trade
Geography
United States
Organisations
None identified
Collected
28th September 2026 · 16:31

Initial assessment ProcIntel's automatic, provisional read of this individual Signal -- Initial Significance and Initial Confidence, computed deterministically before any Event extraction or human review.

A provisional, automatically computed reading of this individual Signal, before Event extraction or human review. Not a final rating.

Significance 2 · Moderate
Confidence 3 · Moderate

Initial Significance Moderate (20.0/100). Strongest contributor: Procurement Impact (12.0/30 points). Limiting factor: Geographic Breadth (0.0/10 points). Initial Confidence Moderate (51.5/100, data sufficiency: Partial). Strongest contributor: Source Authority (40.0/40 points). Limiting factor: Corroboration (2.5/25 points).

Strongest contributor
Procurement Impact
Limiting factor
Geographic Breadth